Advanced Biomed Inc (ADVB): Earnings growth forecast for next year
Strict FDA oversight and patent protection for biopsy IT systems create a significant barrier to entry for competitors. The historical n+1 profit forecast trend on the GURU.Markets chart demonstrates the market reaction, where 0.00 is the current value of the indicator. Advanced Biomed Inc (ADVB) focuses on early tumor detection via circulating cells while adhering to rigorous clean-room assembly standards for microfluidic chips.
Analytical breakdowns and data insights for company Advanced Biomed (ADVB)
- share price and consensus valuation forecast:
- stock exchange capitalization data:
- book capitalization indicators:
- debt and liquidity details:
Total Debt to Capital Advanced Biomed Inc|ADVB - Long-Term Debt to Capital|Short-Term Debt to Equity Advanced Biomed Inc.|ADVB - Company Aggregate Debt|Debts to Book Capitalization Advanced Biomed|ADVB - Company Long-Term Liabilities|Company Short-Term Debts Advanced Biomed|Quick Ratio advanbiomed.com
- earnings and valuation multiples information:
ADVB - Company Profit|Future Profit Advanced Biomed Inc|ADVB - Company Value to Net Income|Forward P/E Multiple Advanced Biomed Inc.|ADVB - Price/Earnings to Growth Ratio|EV/EBITDA Multiple Advanced Biomed|ADVB - Operating income before deduction of amortization|Earnings per share for the last twelve months Advanced Biomed|ADVB - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months advanbiomed.com|ADVB - Net earnings per share growth this year|Earnings growth forecast for next year Advanced Biomed Inc
General company analysis:Advanced Biomed Inc, ADVB
For long-term risk hedging, it is essential for an investor to evaluate the expected net profit dynamics as a measure of the asset's financial stability. This metric measures the percentage growth in earnings per share by comparing current market quotes with expert consensus forecasts. By analyzing the EPS forecast trends for the coming year, one can gauge the commercialization potential of Advanced Biomed Inc (ADVB) liquid biopsy systems in oncology diagnostics.
Analysis of competing companies
ONC (BeiGene Corp) - Earnings growth forecast for next year|Expected net earnings per share growth next year Halozyme Corp HALO|Earnings growth forecast for next year RVMD|Earnings growth forecast for next year ascentage.com (AAPG)|Earnings growth forecast for next year CGON (CG Oncology)|URGN: Projected earnings per share growth rate for next year|BCAX: Expected earnings per share growth for next year|PSNL: Net earnings per share growth forecast for next year|ERAS: Earnings growth forecast for next year|delcath.com (DCTH) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year Y-mAbs Therapeutics, Inc.|Projected earnings per share growth rate for next year AURA (Aura Biosciences Inc)|Earnings growth forecast for next year CADL|Expected earnings per share growth for next year Accuray, Inc. ARAY|Earnings growth forecast for next year SLS (SELLAS Life Sciences Group)|actuatetherapeutics.com (ACTU) - Expected net earnings per share growth next year|Citius Oncology - Earnings growth forecast for next year|HURA (TuHURA Biosciences, Inc.) - Projected earnings per share growth rate for next year|TARA (Protara) - Expected earnings per share growth for next year|Fate Pharma - Expected earnings per share trend next year|WHWK (Aadi Bioscience, Inc.) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year TCRX|Earnings growth forecast for next year CSBR|Consensus forecast of earnings per share growth for next year xbiotech.com|Net earnings per share growth forecast for next year CEL-SCI CVM|OS Therapies, Inc. (OSTX) - Expected net earnings per share growth next year|RADX - Net earnings per share growth forecast for next year|Artiva Biotherapeutics, Inc. (ARTV) - Expected earnings per share growth for next year|ANL: Earnings growth forecast for next year|Expected net earnings per share growth next year Veru Inc (VERU)|TPST (Tempest Tx) - Earnings growth forecast for next year|Projected earnings per share growth rate for next year XLO (Xilio)|Expected earnings per share growth for next year RENB (Renovaro Inc.)|MURA (muraloncology.com) - Expected earnings per share trend next year|Earnings growth forecast for next year KAPA (Kairos Pharma)|Consensus forecast of earnings per share growth for next year OnKure Therapeutics, Inc. (OKUR)|GDTC - Net earnings per share growth forecast for next year|CRIS (Curis, Inc.) - Projected earnings per share growth rate for next year|APLM: Earnings growth forecast for next year|Expected earnings per share growth for next year tharimmune.com|GNPX (Genprex) - Earnings growth forecast for next year|Earnings growth forecast for next year Calidi Bio|Earnings growth forecast for next year SBFM|xeneticbio.com - Projected earnings per share growth rate for next year|Salarius Pharmaceuticals - Expected earnings per share growth for next year|purple-biotech.com - Net earnings per share growth forecast for next year|AON - Earnings growth forecast for next year|BGNE: Net earnings per share growth forecast for next year|CKPT: Earnings growth forecast for next year|Expected earnings per share growth for next year elevationoncology.com|ICAD (iCAD Inc.) - Earnings growth forecast for next year|Earnings growth forecast for next year Ikena|Net earnings per share growth forecast for next year Notable Labs (NTBL)|viracta.com - Projected earnings per share growth rate for next year|Earnings growth forecast for next year MOR (MorphoSys Corp)|NAYA - Expected earnings per share growth for next year|Ascentage Pharma Group - Earnings growth forecast for next year
